IS7833A - Efnasambönd með sameinaða heteróhringi - Google Patents
Efnasambönd með sameinaða heteróhringiInfo
- Publication number
- IS7833A IS7833A IS7833A IS7833A IS7833A IS 7833 A IS7833 A IS 7833A IS 7833 A IS7833 A IS 7833A IS 7833 A IS7833 A IS 7833A IS 7833 A IS7833 A IS 7833A
- Authority
- IS
- Iceland
- Prior art keywords
- heterocyclic compounds
- combined
- combined heterocyclic
- compounds
- heterocyclic
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42445602P | 2002-11-06 | 2002-11-06 | |
| PCT/US2003/035543 WO2004043958A1 (en) | 2002-11-06 | 2003-11-06 | Fused heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7833A true IS7833A (is) | 2005-05-02 |
Family
ID=32312811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7833A IS7833A (is) | 2002-11-06 | 2005-05-02 | Efnasambönd með sameinaða heteróhringi |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7253179B2 (is) |
| EP (1) | EP1562943A1 (is) |
| JP (1) | JP4547266B2 (is) |
| KR (1) | KR20050103184A (is) |
| CN (2) | CN101134757A (is) |
| AU (1) | AU2003285160B2 (is) |
| BR (1) | BR0316070A (is) |
| CA (1) | CA2505372A1 (is) |
| EA (1) | EA009421B1 (is) |
| IS (1) | IS7833A (is) |
| MX (1) | MXPA05004739A (is) |
| NO (1) | NO20052655L (is) |
| NZ (1) | NZ540328A (is) |
| PL (1) | PL376659A1 (is) |
| WO (1) | WO2004043958A1 (is) |
| ZA (1) | ZA200503654B (is) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070135425A1 (en) * | 2001-05-04 | 2007-06-14 | Amgen Inc. | Fused heterocyclic compounds |
| US6809104B2 (en) * | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
| EP1562943A1 (en) | 2002-11-06 | 2005-08-17 | Amgen Inc. | Fused heterocyclic compounds |
| AU2004209505B2 (en) | 2003-02-10 | 2009-07-23 | Banyu Pharmaceutical Co., Ltd. | Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| DE102010025663A1 (de) * | 2010-06-30 | 2012-01-05 | Karl-Heinz Glüsenkamp | Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate |
| KR20130097748A (ko) * | 2010-08-10 | 2013-09-03 | 아비에 인코포레이티드 | 신규한 ｔｒｐｖ３ 조절제 |
| US9012651B2 (en) | 2011-03-24 | 2015-04-21 | Abbvie Inc. | TRPV3 modulators |
| MX2014004979A (es) * | 2011-10-24 | 2014-10-24 | Abbvie Inc | Derivados de metanol como moduladores de trpv3. |
| CN106588812B (zh) * | 2016-12-07 | 2019-02-22 | 烟台大学 | 一种酰氯制备2，4-二取代噻唑啉类化合物的方法 |
| CN120208846A (zh) * | 2019-01-14 | 2025-06-27 | 载度思生命科学有限公司 | 经取代的磺酰脲类衍生物 |
| HUP2200222A1 (hu) | 2022-06-17 | 2023-12-28 | Richter Gedeon Nyrt | MCHR1 antagonisták a Prader-Willi szindróma kezelésére |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US199549A (en) * | 1878-01-22 | Improvement in screw-propellers | ||
| US23085A (en) * | 1859-03-01 | chandler | ||
| US176694A (en) * | 1876-04-25 | Improvement in screw-cutting die-stocks | ||
| JPS5825980B2 (ja) | 1976-02-12 | 1983-05-31 | ヤマサ醤油株式会社 | サイクリックヌクレオチドの定量法 |
| JPS63258474A (ja) | 1986-08-15 | 1988-10-25 | セドナ・ファ−マセウチカルズ・ビ−・ブイ | カルバゾ−ル、ジベンゾフラン又はジベンゾチオフェン基を含む化合物の水酸基誘導体を調製するための方法 |
| US5049655A (en) | 1989-03-22 | 1991-09-17 | The Salk Institute For Biological Studies | Melanin-concentrating hormones |
| JP2906654B2 (ja) | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
| US5401629A (en) | 1990-08-07 | 1995-03-28 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Assay methods and compositions useful for measuring the transduction of an intracellular signal |
| JP3160941B2 (ja) * | 1991-06-17 | 2001-04-25 | 東レ株式会社 | カルバゾール誘導体および免疫抑制剤 |
| DE69232484T2 (de) | 1991-07-05 | 2002-10-31 | Smithkline Beecham S.P.A., Baranzate Di Bollate | Hydroisochinolinderivate |
| FI942499A7 (fi) | 1992-09-29 | 1994-07-27 | Toray Industries | Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö |
| US5272146A (en) | 1992-10-02 | 1993-12-21 | The United States Of America As Represented By The United States Department Of Health And Human Services | 1,2-dihydroellipticines with activity against CNS specific cancer cell lines |
| US5457208A (en) | 1993-06-21 | 1995-10-10 | Regents Of The University Of Minnesota | Kappa opioid receptor antagonists |
| US5464841A (en) | 1993-11-08 | 1995-11-07 | Univ Minnesota | Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
| US5578725A (en) | 1995-01-30 | 1996-11-26 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
| US5849708A (en) | 1995-06-06 | 1998-12-15 | Joslin Diabetes Center, Inc. | Promotion of eating behavior |
| EP0848060A3 (en) | 1996-12-11 | 2000-02-02 | Smithkline Beecham Corporation | Novel human 11CB splice variant |
| DE69822937T2 (de) | 1997-01-16 | 2004-08-12 | Toray Industries, Inc. | Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen |
| US6555339B1 (en) | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
| JP2001525178A (ja) | 1997-12-03 | 2001-12-11 | スミスクライン ビーチャム コーポレーション | ヒト１１ｃｂスプライス変異体に対するアゴニストおよびアンタゴニストの探索方法 |
| AU742425B2 (en) | 1998-06-11 | 2002-01-03 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
| WO2000015793A2 (en) | 1998-09-17 | 2000-03-23 | Incyte Pharmaceuticals, Inc. | Human gpcr proteins |
| GB9822158D0 (en) | 1998-10-09 | 1998-12-02 | Nycomed Imaging As | Compositions |
| CA2356412A1 (en) | 1998-12-28 | 2000-07-13 | Takeda Chemical Industries, Ltd. | Screening method |
| US6221613B1 (en) | 1998-12-31 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| WO2000049170A1 (en) | 1999-02-18 | 2000-08-24 | Smithkline Beecham Corporation | MURINE 11cby RECEPTOR |
| CN1341123A (zh) | 1999-02-19 | 2002-03-20 | 武田药品工业株式会社 | 新型g蛋白偶联型受体蛋白及其dna |
| CA2372980A1 (en) | 1999-05-19 | 2000-11-23 | Astrazeneca Ab | Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1) |
| AU5869100A (en) | 1999-06-08 | 2000-12-28 | Regents Of The University Of California, The | Melanin concentrating hormone receptor |
| EP1200560A4 (en) | 1999-07-14 | 2003-06-11 | Merck & Co Inc | MELANINE-CONCENTRATING HORMONE RECEPTOR |
| JP2003505082A (ja) | 1999-07-26 | 2003-02-12 | ジェネンテック・インコーポレーテッド | 新規なポリヌクレオチドとその使用法 |
| WO2001007606A1 (en) | 1999-07-27 | 2001-02-01 | Smithkline Beecham Plc | Axor21, a g-protein coupled receptor |
| CA2386474A1 (en) | 1999-09-20 | 2001-03-29 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonist |
| WO2001021169A1 (en) | 1999-09-20 | 2001-03-29 | Takeda Chemical Industries, Ltd. | Mch antagonists |
| EP1233981A4 (en) | 1999-11-16 | 2003-02-12 | Merck & Co Inc | RECEPTOR COUPLED TO A G-PROTEIN |
| JP2001226269A (ja) | 2000-02-18 | 2001-08-21 | Takeda Chem Ind Ltd | メラニン凝集ホルモン拮抗剤 |
| JP2003532388A (ja) | 2000-03-15 | 2003-11-05 | メルク エンド カムパニー インコーポレーテッド | メラニン凝集ホルモン受容体キメラおよび融合タンパク質 |
| JP2005229804A (ja) | 2000-03-24 | 2005-09-02 | Astellas Pharma Inc | 新規なメラニンコンセントレーティングホルモン受容体 |
| US7229986B2 (en) | 2000-05-16 | 2007-06-12 | Takeda Pharmaceutical Company Ltd. | Melanin-concentrating hormone antagonist |
| AU783403B2 (en) | 2000-07-05 | 2005-10-20 | H. Lundbeck A/S | Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
| US7273710B2 (en) | 2000-07-05 | 2007-09-25 | Takeda Pharmaceutical Company Limited | Method for screening MCH receptor antagonist/agonist |
| EP1246847A2 (en) | 2000-07-05 | 2002-10-09 | Synaptic Pharmaceutical Corporation | Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| EP1366030A2 (en) | 2000-07-06 | 2003-12-03 | Neurogen Corporation | Melanin concentrating hormone receptor ligands |
| AP2001002307A0 (en) | 2000-10-20 | 2001-12-31 | Pfizer Prod Inc | B3 adrenergic receptor agonists and uses thereof. |
| US20030022891A1 (en) | 2000-12-01 | 2003-01-30 | Anandan Palani | MCH antagonists and their use in the treatment of obesity |
| ATE302185T1 (de) * | 2000-12-22 | 2005-09-15 | Schering Corp | Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität |
| AU2002247367B2 (en) | 2001-03-21 | 2005-10-27 | Pharmacopeia Drug Discovery, Inc. | Aryl and biaryl compounds having MCH modulatory activity |
| US6900329B2 (en) | 2001-03-21 | 2005-05-31 | Schering Corporation | MCH antagonists and their use in the treatment of obesity |
| MXPA03009353A (es) * | 2001-04-12 | 2004-02-12 | Pharmacopeia Inc | Aril y biaril piperidinas utilizadas como antagonistas de mch. |
| US6809104B2 (en) | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
| CA2446351A1 (en) | 2001-05-04 | 2002-11-14 | Tularik Inc. | Fused heterocyclic compounds |
| CN1703401A (zh) | 2001-05-22 | 2005-11-30 | 神经原公司 | 黑色素浓集激素受体的配体:取代的1－苄基－4－芳基哌嗪类似物 |
| DE60234116D1 (de) * | 2001-11-26 | 2009-12-03 | Schering Corp | Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität und störungen des zentralnervensystems |
| US7160879B2 (en) | 2002-01-10 | 2007-01-09 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues |
| EP1562943A1 (en) | 2002-11-06 | 2005-08-17 | Amgen Inc. | Fused heterocyclic compounds |
-
2003
- 2003-11-06 EP EP03779483A patent/EP1562943A1/en not_active Withdrawn
- 2003-11-06 NZ NZ540328A patent/NZ540328A/en unknown
- 2003-11-06 PL PL376659A patent/PL376659A1/pl not_active Application Discontinuation
- 2003-11-06 CA CA002505372A patent/CA2505372A1/en not_active Abandoned
- 2003-11-06 CN CNA2007101119484A patent/CN101134757A/zh active Pending
- 2003-11-06 CN CNB2003801082225A patent/CN1330651C/zh not_active Expired - Fee Related
- 2003-11-06 ZA ZA200503654A patent/ZA200503654B/en unknown
- 2003-11-06 JP JP2004551872A patent/JP4547266B2/ja not_active Expired - Fee Related
- 2003-11-06 KR KR1020057008174A patent/KR20050103184A/ko not_active Withdrawn
- 2003-11-06 WO PCT/US2003/035543 patent/WO2004043958A1/en not_active Ceased
- 2003-11-06 EA EA200500770A patent/EA009421B1/ru not_active IP Right Cessation
- 2003-11-06 BR BR0316070-0A patent/BR0316070A/pt not_active IP Right Cessation
- 2003-11-06 US US10/705,173 patent/US7253179B2/en not_active Expired - Fee Related
- 2003-11-06 AU AU2003285160A patent/AU2003285160B2/en not_active Ceased
- 2003-11-06 MX MXPA05004739A patent/MXPA05004739A/es active IP Right Grant
-
2005
- 2005-05-02 IS IS7833A patent/IS7833A/is unknown
- 2005-06-02 NO NO20052655A patent/NO20052655L/no not_active Application Discontinuation
-
2007
- 2007-07-26 US US11/881,805 patent/US20080058365A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050103184A (ko) | 2005-10-27 |
| AU2003285160B2 (en) | 2009-06-04 |
| EP1562943A1 (en) | 2005-08-17 |
| CN1330651C (zh) | 2007-08-08 |
| US20080058365A1 (en) | 2008-03-06 |
| BR0316070A (pt) | 2005-09-27 |
| MXPA05004739A (es) | 2005-08-02 |
| JP4547266B2 (ja) | 2010-09-22 |
| ZA200503654B (en) | 2006-09-27 |
| NO20052655L (no) | 2005-07-26 |
| NO20052655D0 (no) | 2005-06-02 |
| EA200500770A1 (ru) | 2005-12-29 |
| EA009421B1 (ru) | 2007-12-28 |
| AU2003285160A1 (en) | 2004-06-03 |
| CN101134757A (zh) | 2008-03-05 |
| WO2004043958A1 (en) | 2004-05-27 |
| PL376659A1 (pl) | 2006-01-09 |
| US20040147538A1 (en) | 2004-07-29 |
| CN1735613A (zh) | 2006-02-15 |
| NZ540328A (en) | 2008-02-29 |
| CA2505372A1 (en) | 2004-05-27 |
| US7253179B2 (en) | 2007-08-07 |
| JP2006508130A (ja) | 2006-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7471A (is) | Ný efnasambönd | |
| ATE368042T1 (de) | Cephemverbindungen | |
| IS8348A (is) | Samrunnin heteróhringasambönd | |
| IS7879A (is) | Ný efnasambönd | |
| ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
| ATE460418T1 (de) | Heterocyclocarboxamidderivate | |
| DE60330372D1 (de) | Indol-3-schwefelderivate | |
| ATE467631T1 (de) | Chinuclidinamidderivate | |
| ATE438644T1 (de) | Chinazolinderivate | |
| IS7381A (is) | Efnasambönd | |
| NO20044046L (no) | Substituerte hydroksyetylaminer | |
| IS7414A (is) | Oxó-azabísýklísk efnasambönd | |
| DE602004019555D1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone | |
| NO20045659L (no) | Forbindelser | |
| ATE335729T1 (de) | 3h-chinazoline -4-on derivaten | |
| IS7793A (is) | Nýtt efnasamband | |
| IS7827A (is) | Ný efnasambönd | |
| IS7794A (is) | Nýtt efnasamband | |
| ATE496887T1 (de) | Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide | |
| ATE423771T1 (de) | Tetrahydrochinolinderivate | |
| IS7833A (is) | Efnasambönd með sameinaða heteróhringi | |
| DE50306277D1 (de) | 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate | |
| ATE350379T1 (de) | Substituierte benzdioxepine | |
| SE0201185D0 (sv) | Heterocyclic compounds | |
| SE0203606D0 (sv) | Heterocyclic compounds |